Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
UHPLC-MS-Based Analysis of Fluvoxamine in Rabbit Aqueous Humour and Serum: Method Development and ValidationAndrea Guba, Anna Takácsi-Nagy, Sourav Das, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
The Sigma-1 Receptor Agonist Fluvoxamine Is Protective in Hyperglycaemia-Induced Dysfunction of Trabecular Meshwork CellsAlexandra Rozsahegyi, Marcell Cserhalmi, Timea Medveczki, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 27, 2013
Chronic vasodilation increases renal medullary PDE5A and α-ENaC through independent renin-angiotensin-aldosterone system pathwaysCrystal A West, Stefan Shaw, Jennifer M Sasser, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 22, 2011
Gender differences in serum and glucocorticoid regulated kinase-1 (SGK-1) expression during renal ischemia/reperfusion injuryKrisztina Rusai, Agnes Prókai, Beáta Szebeni, et al.
Hypertension (Dallas, Tex. : 1979)|June 23, 2010
Reference values of pulse wave velocity in healthy children and teenagersGeorge S Reusz, Orsolya Cseprekal, Mohamed Temmar, et al.
Pediatric Research|November 29, 2007
Pulse wave velocity in end-stage renal disease: influence of age and body dimensionsEva Kis, Orsolya Cseprekál, Zsófia Horváth, et al.
International Journal of Molecular Sciences|January 8, 2025
Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney DiseaseDora B Balogh, Judit Hodrea, Adar Saeed, et al.
Pageof 9